热不燃烧,电子烟和香烟对小气道功能的影响
L Jung1,2, I C Buchwald1, A Hauck1
1Medical Clinic III, Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany.
Tobacco use insights
|September 24, 2024
概括
新的研究表明,电子烟和加热烟草制品 (HTP) 与传统香烟具有类似的血液动力学效应. 含尼古丁的电子烟也会对小气道产生负面影响,挑战这些产品是健康的替代品的说法.
科学领域:
- 心血管生理学心血管生理学
- 肺部医学 肺部医学
- 烟草产品研究 烟草产品研究
背景情况:
- 电子烟和加热烟草制品 (HTP) 越来越受欢迎,被推销为传统香烟的更安全替代品.
- 这些新型烟草产品对健康的长期影响需要彻底调查.
研究的目的:
- 为了比较吸烟常规香烟,vaping IQOS和vaping电子香烟 (含尼古丁或不含尼古丁) 的急性心血管和呼吸系统影响.
- 评估对血液动力学,动脉硬和小气道功能的影响.
主要方法:
- 这是一项四臂交叉研究,涉及20名偶尔吸烟者 (10名男性,10名女性).
- 参与者完成了四个研究手臂:传统香烟吸烟,IQOS电子烟,含尼古丁的电子烟和无尼古丁的电子烟,手臂之间至少有48小时的洗时间.
- 使用Mobil-O-GraphTM测量血液动力学和动脉硬度,使用tremoFlo® c-100.00评估小气道功能.
主要成果:
- 传统的香烟,IQOS和含尼古丁和无尼古丁的电子烟都对血液动力学和动脉硬产生了类似的急性影响.
- 所有测试的产品都导致测量的血液动力学和动脉硬度参数显著增加.
- 含有尼古丁的产品 (香烟,IQOS和尼古丁电子烟) 独特地导致支气管阻塞增加,反应力更高,潮体积更大.
结论:
- 传统的香烟,IQOS和电子烟对心血管血液动力学和动脉硬性产生类似的急性影响.
- 虽然无尼古丁的电子烟在血液动力学影响方面与含尼古丁的电子烟没有区别,但所有含尼古丁的产品都对小呼吸道功能产生了不利影响.
- 这些发现表明,电子烟和HTP并不是比传统香烟更健康的替代品,特别是在呼吸系统健康方面.
关键词:
每一个人都有 EVALI.慢性肺病是一种慢性肺病.这是一支烟草,一支香烟.电子烟电子烟是一种电子烟.热 - 不燃烧 - 没有燃烧.小气道的功能是小的.小型航空公司吸烟是为了吸烟.在Tremophilus的研究中,更多相关视频
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
11.5K
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
8.3K
相关概念视频
Stimulants
167
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
167
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Factors Affecting Pulmonary Ventilation
1.3K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
1.3K
COPD: Pathogenesis and Clinical Features
243
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
243
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
